Document is current
Any future updates will be listed below
-
Authors
Shapiro, Robert E.
Viktrup, Lars
Muenzel, Eva Jolanda
Buse, Dawn C.
Zagar, Anthony J.
Ashina, Sait
Hutchinson, Susan
Nicholson, Robert A.
Lipton, Richard B.
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 7 November 2024
Accepted: 15 January 2025
First Online: 12 March 2025
Declarations
:
: All participants provided electronic informed consent. This observational study was approved by the Sterling Institutional Review Board (IRB ID #6425-001).
: Not applicable.
: Funding for this study was provided by Eli Lilly & Company. LV, EJM, AJZ, RAN: employees of Eli Lilly & Company. RES: consulting fees from Eli Lilly & Company, Theranica; travel or meeting support from Eli Lilly & Company; participation on monitoring or advisory board with Eli Lilly & Company; leadership or fiduciary role with Headache Cooperative of New England. DB: consulting fees from AbbVie, Biohaven, Collegium, Eli Lilly & Company, Lundbeck, Teva, Theranica; payment or honoraria from Lundbeck, Teva; participation on monitoring or advisory board with AbbVie, Eli Lilly & Company, Lundbeck, Teva. SA: consulting fees from AbbVie/Allergan, Eli Lilly & Company, Lundbeck, Theranica, Linpharma, Satsuma, Pfizer; payment or honoraria from Teva, Eli Lilly & Company, Lundbeck; leadership or fiduciary role with Educational Committee of HIS, trustee of HIS board. SH: consulting fees from AbbVie, Amgen, Biohaven, Impel, Eli Lilly & Company, Lundbeck, Theranica, Upsher Smith; payment or honoraria from AbbVie, Biohaven, Impel, Eli Lilly & Company, Lundbeck, Teva, Theranica, Upsher Smith. RBL: grants or contracts from US Food & Drug Administration, Migraine Research Foundation, National Headache Foundation; royalties or licenses from Wolff’s Headache 7th and 8th Edition, Oxford Press University, 2009, Wiley and Informa; consultant, advisory board member, or received honoraria from AbbVie (Allergan), American Academy of Neurology, American Headache Society, Amgen, Avanir, Axon, Axsome, Biohaven, Biovision, Boston Scientific, Dr. Reddy’s (Promius), Electrocore, Eli Lilly & Company, eNeura Therapeutics, Equinox, GlaxoSmithKline, Grifols, Lundbeck (Alder), Manistee, Merck, Pernix, Pfizer, Satsuma, Supernus, Teva, Trigemina, Vector, Vedanta; stock or stock options from Axon, Biohaven Holdings, CoolTech, Manistee.
